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AbstrAct
During the last decade the nematode Caenorhabditis elegans has been used to mod-
el the pathogenesis of several bacterial species. The emerging pathogen enteroag-
gregative Escherichia coli (EAEC) is a considerable cause of both acute and persis-
tent diarrhea worldwide. Travellers to developing countries, immunocompromised 
people and young children are high-risk groups prone to infection. Virulence mod-
els using C. elegans might provide valuable information about the host-pathogen 
interactions which can be used in the treatment of infection with EAEC.
It is investigated if the enteroaggregative E. coli 042 is pathogenic to the C. elegans 
mutant AU37. The use of C. elegans as a virulence model for E. coli 042 is further 
considered. This is examined via a killing assay where C. elegans grasses on a lawn 
of E. coli 042 compared to grassing on apathogenic E. coli OP50. The mode of 
infection by E. coli 042 in C. elegans is studied by substituting the lawn with GFP-
marked strains of E. coli 042 and OP50.
E. coli 042 is shown to be pathogenic towards C. elegans and the worm is demon-
strated as a suitable virulence model for E. coli 042. It is shown by photo micros-
copy that the GFP-marked E. coli 042 colonize the intestine of C. elegans. It was 
attempted to transfer the pAA2 virulence plasmid from E. coli 042 into E. coli OP50 
to examine whether this renders OP50 pathogenic towards C. elegans. Unfortu-
nately the transfer did not succed and additional studies are necessary to investigate 
the role of the pAA2 plasmid in the virulence of E. coli 042.
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resumé
Nematoden Caenorhabditis elegans er i løbet af det seneste årti blevet benyttet som virulensmodel for 
flere forskellige patogene bakteriestammer. Den enteroaggregative patogene bakterie E. coli (EAEC), af 
stammen 042, kan forårsage både akut og vedvarende diarré hos mennesker. Rejsende i udviklingslande, 
immunkompromitterede personer samt børn er grupper særligt udsatte for infektion. Viden om interak-
tioner mellem værtsorganisme og den patogene bakterie, der fører til sygdomsudvikling, er nødvendig for 
at kunne udvikle effektive behandlingsmetoder. Anvendelsen af C. elegans vil muligvis kunne hjælpe til 
at opnå denne viden.
I dette projekt undersøges om E. coli 042 er patogen overfor C. elegans mutanten AU37 og derudover 
vurderes C. elegans som virulensmodel for E. coli 042. Dette gøres ved at sammenligne en række kill-
assays, hvor C. elegans lever på E. coli 042 og den apatogene E. coli OP50. Hvilken type infektion E. coli 
042 etablerer i C. elegans undersøges ved at lade ormen leve på GFP-mærkede stammer af E. coli 042 og 
OP50.
Det konkluderes at E. coli 042 er patogen overfor C. elegans, der yderligere vurderes som en god virulens-
model for denne bakteriestamme. Ydermere vises det, ved hjælp af fotomikroskopi, at den GFP-mærkede 
E. coli 042 koloniserer tarmen i C. elegans. Ved at transformere virulensplasmidet pAA2 fra E. coli 042 
til E. coli OP50, undersøges det hvorvidt plasmidet gør OP50 patogen overfor C. elegans. Desværre lykk-
edes overførslen af pAA2 til E. coli OP50 ikke, hvorfor yderligere studier er nødvendige for at klarlægge 
plasmidets rolle i virulensen af E. coli 042.
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1. introduction
The bacterium Escherichia coli is usually a nontoxic natural commensal living in the gastrointestinal tract 
of humans and other mammals. Nevertheless some strains of E. coli have diverged from the traditional 
habit adapting certain pathogenic characteristics enabling them to cause human diseases (Harrington et 
al., 2006).
Enteroaggregative E. coli (EAEC) is a human pathogen mainly known for causing diarrheal illness. 
Several studies show that both acute and chronic diarrhea in children, adults and immunocompromised 
people can result from infections by EAEC (Huang et al., 2006). Furthermore EAEC was shown to be 
the second most common agent to cause travellers diarrhea in a total of 51 published studies (Shah et al., 
2009). Enterotoxigenic E. coli (ETEC) is the most common cause (Huang et al., 2006). EAEC have lead 
to numerous diarrheal outbreaks in different parts of Europe and Asia. Furthermore, EAEC have been as-
sociated with diarrheal incidents in the U.S where the reported cases have been connected with the inges-
tion of bacteria-contaminated food (Huang et al., 2006). In addition EAEC strain 042 has been shown to 
cause diarrhea in the majority of volunteers in studies by Nataro et al. The connection between EAEC and 
diarrhea shown in scientific studies using mice, piglets and rabbits together with diarrheal outbreaks in 
both the developed and developing parts of the world, confirms that some strains of EAEC are definitely 
human pathogens (Kang et al., 2001). 
The virulence and pathogenesis of bacteria are crucial in understanding the diseases they cause. The 
knowledge is highly necessary in the development of novel antimicrobial agents (Harrington et al., 2006). 
Animal virulence models have been used for decades to determine the pathogenesis of bacteria. During 
recent years a new type of animal model has emerged; simple organisms as virulence models has proven 
to be suitable to study bacterial pathogenesis. The nematode Caenorhabditis elegans has been used as a 
virulence model to study several human pathogens in a number of experiments and is now recognized as 
a suitable host to examine aspects of bacterial pathogenesis (Sifri et al., 2005).
EAEC and other pathogenic E. coli can be divided into different pathotypes on the basis of the disease 
that they cause and the virulence factors they contain (Kaper et al., 2004; Kaper, 2005). A key virulence 
factor of the EAEC and strain 042 is the transcriptional activator AggR located on the pAA2 plasmid. 
(Chaudhuri et al., 2010). AggR activates genes encoding the proteins which results in the aggregative ad-
herence phenotype (Harrington et al., 2006). Several studies support the hypothesis that AggR is involved 
in the expression of chromosomal virulence factors besides the virulence factors located on the plasmid 
itself. Thus, AggR acts as the primary regulator of EAEC pathogenesis (Nataro, 2005).
The following questions will be addressed throughout the report:
 Is E. coli 042 pathogenic to C. elegans AU37?
 Can C. elegans be used as a virulence model for E. coli 042?
 By what mode of infection does E. coli 042 kill C. elegans?
 Does the pathogenesis of E. coli 042 towards C. elegans result from the pAA2 plasmid?
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2. enteroAggregAtive EschErichia coli
E. coli is a facultative anaerobic Gram-negative rod-shaped coliform bacterium normally located in the 
lower intestines of warm-blooded organisms. The apathogenic strains are a natural part of the flora in the 
human gut where they exist in symbiosis. Most E. coli strains are harmless but malignant pathotypes exist 
and are causative agents of intestinal diseases like diarrhea (Neidhardt, 1996). The different pathogenic 
E. coli strains can be divided into pathotypes according to their pathogenicity. EAEC is one pathotype, 
characterized by the exhibition of the aggregative adherence pattern, which is also known as the stacked 
brick pattern, see picture 2.1.
2.1 Discovery
E. coli have been implicated as agents of diarrheal disease since 
the 1920s. One type of E. coli classification determined in 1979 by 
Cravioto et al. stated that most enteropathogenic E. coli (EPEC) 
adhered to human epidermoid cancer (HEp-2) cells in culture. 
Cravioto et al. discovered that the adherence phenotype could be 
used to distinguish between EPEC and non-EPEC bacteria. Further 
studies showed that E. coli not of the EPEC pathotype adhered 
to semiconfluent HEp-2 cells, but the adherence phenotype was 
clearly different from that induced by EPEC. The adherence pattern 
of EPEC was localized and the non-EPEC pattern was diffuse, see 
figure 2.1 (Nataro et al., 1998). It turned out that the diffuse ad-
herent strains (DA) could be further divided into two phenotypic 
subcategories; aggregative and true diffuse.
In a study of paediatric diarrhea in Santiago, Chile the causative agent of disease was found to be only 
the aggregative strains. This led the investigators to propose two independent categories: enteroaggrega-
tive (EAEC) and diffusely adherent E. coli (Nataro et al., 1998). This resulted in the definition of EAEC 
to be “E. coli that do not secrete heat-labile or heat-stable enterotoxins and adhere to HEp-2 cells in an 
aggregative pattern”. The aggregative adherence (AA) pattern is shown on picture 2.1. EAEC was first 
described in 1987 (Nataro et al., 1998).
Figure 2.1 Taxonomical diagram of re-
spective E. coli (The Authors).
Picture 2.1 Adherence patterns of EAEC strains. Diffuse adherence (DA) and aggregative adherence (AA) 
(Okeke et al., 2007).
AADA
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2.2 epiDemiology
According to Ruttler et al. and Nataro et al. enteroaggregative E. coli is known to have caused large diar-
rheal outbreaks in different parts of Europe, America and Japan. EAEC is also a common bacterial cause 
of diarrhea among travellers to developing countries, among children and HIV-infected persons residing 
in developing and developed regions of the world. EAEC is a cause of persistent diarrhea; cases where 
infection lasts for more than 14 days. It is also a common cause of acute diarrheal illness in children and 
adults presenting to emergency departments and inpatient units in the U.S. (Huang et al., 2006). Listed in 
table 2.1 is a collection of several diarrheal EAEC outbreaks. The first incidence where EAEC was clearly 
implicated was in 1995 at a nursery in Nis, Siberia and involved 19 infants.
Owing to data from volunteer studies and investigations of outbreaks the pathogenicity of several EAEC 
strains towards humans have been demonstrated. Both acute and persistent diarrhea have been found.
2.3 pathogenesis
The pathogenesis of EAEC is complex. Human and animal studies 
indicate that EAEC is able to bind to jejunal, ileal and colonic epithe-
lium, see figure 2,2 (Huang et al., 2006). A complete understanding 
of all the different factors accountable for the virulence has yet to 
be determined, although certain chromosomal and plasmid carried 
genes have been identified to play an essential role (Harrington et 
al., 2006).
EAEC strain 042 is characterized as a typical EAEC strain 
due to the fact that it contains a cluster of AggR dependent vir-
ulence genes (Elias et al., 1999; Nataro, 2005). E. coli 042 
carries most of the genes believed to be responsible for patho-
genesis on the 100kb plasmid pAA2 (Fujiyama et al., 2008). 
However, a pathogenicity island on the bacterial chromo-
some has also been suggested to contain genes which mediate pathogenesis (Dudley et al., 2006). 
It is generally recognized that the pathogenesis of EAEC can be divided into three different stages being 
adherence and colonization, biofilm formation and lastly inflammation and toxin secretion (Harrington et 
al., 2006). This classification is troubled by the fact that there is great diversity between different EAEC 
strains and the pathogenicity varies between strains. It should be noted that not all EAEC strains are 
pathogenic, exemplified by the fact that only one out of four EAEC strains given to volunteers resulted in 
diarrhea (Nataro et al., 1995).
Setting Patients Illness
Nursery; Nis, Serbia, 1995 19 infants Watery diarrhea
Conference Center, UK, 1994 51 adults Watery diarrhea for 3-7 days
Hotel, UK, 1994 53 adults Water diarrhea, mean duration 68 hours
Village in southern India, 1996 20 children Water diarrhea, mean duration 11 days
and adults
Nursery, Mexico City Not reported Severe diarrhea; 5 deaths
16 schools, Gifu Japan
2.697 school chil-
dren Diarrhea; some cases protracted
Table 2.1 Outbreaks of enteroaggregative E. coli diarrhea (Nataro et al., 1998).
Figure 2.2 The human gastro intestinal 
tract (Zimmermann et al., 2007).
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2.3.1 Adherence and colonization
A crucial step in pathogenesis is adherence to the epithelium of the gastrointestinal tract. This is related 
to the biogenesis of aggregative adherence fimbriae (AAF), see figure 2.2 (Czeczulin et al., 1997). Three 
typical types of AAF (AAF/I, AAF/II, AAF/III), together with a newly found adhesin encoded by the hda 
gene cluster, have been identified so far (Boisen et al., 2008). The newly found adhesin was designated 
AAF/IV and together with the other AAFs it was hypothesized that these AAFs could account for the ma-
jority of the AA phenotypes displayed by the EAEC strains (Boisen et al., 2008). However, only one type 
of AAF is displayed by each EAEC isolate (Kaur et al., 2010). The 042 strain display the AAF/II (Elias et 
al., 1999) which mainly consists of two fimbrial components. The protein component AafA is responsible 
for adhesion and thought to be located at the tip of the pilus, whereas the AafB subunit is implicated in the 
inflammatory response (Farfan et al., 2008).
The ability of the fimbriae to stretch out from the bacteria and thereby 
conferring adherence is highly dependent of the protein dispersin 
which has a positive charge (Velarde et al., 2007). Dispersin serves 
to neutralize the otherwise negatively charged lipopolysaccharides on 
the bacterial surface and thereby allows for the positively charged 
fimbriae to stick out without any charge obstruction (Harrington et 
al., 2006; Huang et al., 2006; Velarde et al., 2007). Interestingly, 
mutants unable to synthesize dispersin actually elicited a hyperag-
gregative phenotype in vitro but failed to colonize the intestinal tract 
when tested in mice (Velarde et al., 2007; Harrington et al., 2009). 
The impaired ability of dispersin mutants to colonize is hypothesized 
to be caused by not being able to penetrate the mucus layer in the 
gastrointestinal tract (Sheikh et al., 2002). For dispersin to display its 
functions as a charge neutralizer it has to be situated on the outer mem-
brane of the bacteria. This requires an ATP-binding cassette transport 
cluster encoded by the aat complex comprised of five genes which are 
under the control of the transcription regulator protein AggR (Nishi 
et al., 2003).   
The general consensus is that colonization is highly dependent on 
AAF, however mutants unable to synthesize AAF displayed the same 
degree of colonization as the wild type when tested in mice (Harrington et al., 2009).
Together with AAF other factors have been shown to play a role in adherence and colonization. An 
outer membrane protein encoded by the hra1 gene has been shown to be sufficient to display both the 
AA phenotype and biofilm formation when introduced in E. coli that under normal circumstances did 
not display any of these features. In contrast, mutants not expressing the gene maintained the ability to 
adhere and form biofilm. Overall, the conclusion is that hra1 is an important part of the genes involved 
in colonization because the mutants displayed a less tidy stacked brick pattern when compared to the 
wild type (Bhargava et al., 2009). Another study revealed that a serine autotransporter encoded by the 
pic gene, which conferred aggregation of red blood cells and decreased viscosity in the mucus layer, was 
important in colonization (Harrington et al., 2009). It was suggested that the pic gene enabled the bacteria 
to utilize mucus for metabolism which is important when preferred nutrition, such as glucose, is scarce. 
(Harrington,  et al., 2009). Furthermore it should be noted that the transcription of the pic gene increased 
54-fold when grown in a fermentor that simulated intestinal condition (Behrens et al., 2002). 
A comparison of the aggregative phenotype between various 042 mutants underlined the importance of 
aggR and the aafA genes in this matter. It also revealed that TolC, an efflux pump, which is a part of the 
aat complex, was relatively important. tolC is considered to be the first chromosomal gene involved in 
EAEC aggregation in aqueous environments and was shown not to require AggR for transcription (Imuta 
et al., 2008).
Picture 2.2 The long, sticky fimbriae of 
E. coli allowing adherence and forma-
tion of biofilm (Gross, 2006).
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Adherence is hereby shown to rely on multiple different factors that altogether contribute in various ways 
to display the AA phenotype. From these studies it is difficult to deduce the relative importance of the 
mentioned genes, with the exception that AAF and dispersin stand out as the single most important factors 
in adherence and colonization.
2.3.2 Biofilm formation
It is suggested that biofilm formation is a two-step process where bacteria aggregate on a surface followed 
by formation of multiple layers of biofilm, see picture 2.3 (Fujiyama et al., 2008). This seems to induce 
extensive colonization and to be highly dependent on the expression of AAF. AAF can form a scaffold-
like structure that allows for mucus and other secretions to gather and eventually confer biofilm charac-
teristics (Huang et al., 2006).
Several genes have been suggested to play a role in biofilm formation, namely the fis, yafK and shf genes. 
It was determined from transposon mutagenesis studies that the fis gene affected biofilm formation by 
inducing transcription of AggR (Sheikh et al., 2001). The yafK gene was found to encode a protein which 
affected the transcription of AAF/II genes and was designated to be less important than the fis gene 
(Sheikh et al., 2001). Additionally the shf gene, controlled by AggR, is a noteworthy co-factor in biofilm 
formation. So far no precise function of the shf gene product has been deduced but since the gene was 
not required for adherence, it appears only to be of importance in the last step of biofilm formation after 
adherence has taken place (Fujiyama et al., 2008).
These data suggest a clear correlation between the ability to express AAF and the capability to form 
biofilm. All the genes involved in biofilm formation interacts with AggR which makes it the key element 
in biofilm formation. 
2.3.3 Inflammation and toxin secretion
The human response to infection by EAEC varies according to the strain in question. The inflammatory 
response is dependent on the innate immune system of the host (Huang et al., 2006; Kaur et al., 2010). 
Inflammation is seen by an increased level of various inflammation markers including Interleukin-8 
(Steiner et al., 2000). Flagellin has been proposed as the main mediator of inflammatory response since it 
caused Interleukin-8 release from various cell lines. Harrington et al. suggested that AggR, and in particu-
lar AAF, was imperative in inflammation as well (Harrington et al., 2005). The general consensus seem 
to be that the complete understanding of the different mediators of inflammation is yet to be discovered 
and is likely to comprise of interactions by multiple factors (Harrington et al., 2005; Kaur et al., 2010).
Damage to the tips and side of the intestinal villi, as a part of EAEC infection, has been associated with 
the release of toxins.
Picture 2.3 Electron microscopy of 042 biofilm after 6h growth on glass in high-glucose MEM. A: 41000x magnification; 
bar= 1,0 µM. B: 2000x magnification; bar = 10µm (Sheikh et al., 2001).
BA
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Namely three toxins has been implicated in EAEC pathogenesis (Huang et al., 2006; Kaur et al., 2010). 
One of the toxins secreted by EAEC, designated plasmid-encoded toxin (Pet), has been identified as a 
108kDa protein of the autotransporter family (Eslava et al., 1998). Pet has been shown to induce dila-
tion of crypt openings together with other abnormalities when tested on rat colonic tissue (Henderson 
et al., 1999). It has specifically been associated with cleavage of cytoskeleton proteins in the microvilli 
(Huang et al., 2006). Although there are several indications that propose a fundamental role of Pet in 
pathogenesis a correlation between damaged T84 human cells and Pet was not obtained (Henderson et 
al., 1999). Furthermore, only 5 out of 55 tested EAEC strains had the pet gene. One of the strains that did 
have the gene was the 042 strain (Boisen et al., 2009). The chromosomal setBA genes, which encodes 
the Shigella enterotoxin 1 (ShET-1), are located on the opposite strand in an overlapping fashion of the 
pic gene. As the name indicates, the toxin is closely related to Shigella enterotoxin which has caused 
fluid accumulation in a rabbit model (Harrington et al., 2006). The precise mode of toxicity has not 
been revealed but it has been proved not to rely on the typical intestinal secretion mediators such as 
cAMP and cGMP (Fasano et al., 1997). The secretion of ShET-1 increased dramatically when tested in 
conditions that simulated the human intestine compared to conventional in vitro conditions (Behrens et 
al., 2002). This could indicate a role in human pathogenesis since expression is higher in the intestine. 
The plasmid gene astA encodes the EAST1 toxin similar to the ETEC heat-stable toxin which causes fluid 
and electrolyte secretion in the intestinal lumen (Qadri et al., 2005). It should be noted that EAST1 is also 
present in apathogenic EAEC and does not appear to be essential for pathogenesis (Nataro et al., 1995).
Overall, there seem to be indication of a noteworthy role of EAST1 and Pet toxins in pathogenesis, even 
though none of them appear to solely confer pathogenesis. This is emphasized due to the fact that they 
are also present in apathogenic EAEC strains. The chromosomal setBA gene could be assumed to have 
a more important role since it has been associated with increased expression under simulated intestinal 
conditions, and could presumably exhibit a greater deal of conservation in EAEC strains because of its 
position on the chromosome. As recapitulation, it is worth noting that all the reviewed genes, except for 
the setBA and tolC, are located on the pAA2 plasmid. This is illustrated in table 2.2 where the respective 
genes are located on the pAA2 plasmid unless stated otherwise.
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2.4 Diagnosis
Colonization of EAEC is detected by isolating E. 
coli from stool samples and demonstrating the AA 
pattern also referred to as the stacked brick pattern, 
see picture 2.4. This can be accomplished in several 
ways with the HEp-2 assay (Cravioto et al., 1979).
The aggregative adherence phenotype is suggested 
to be encoded by a number of plasmids altogether 
called pAA (Vial et al., 1988). Due to this EAEC 
is commonly diagnosed by using a highly specific 
DNA probe which base pairs with sequences from 
these pAA plasmids and is in this way easily dis-
tinguishable from other E. coli strains. Baudry et 
al. invented the technique by testing DNA frag-
ments derived empirically from the plasmid of E. 
coli strains 17-2 and 042. Diagnosing EAEC iso-
lates with this technique has the disadvantage of not 
being able to distinguish pathogenic and apathogenic EAEC strains (Cohen et al., 2005). The pathogenic-
ity island, located on the bacterial chromosome, has been suggested to be the largest continuous region, 
which is not present in the standard apathogenic E. coli MG1655. Due to this difference the region could 
also function as a way of diagnosing typical EAEC strains (Dudley et al., 2006). A PCR assay using 
primers derived from the AA probe sequence can also be used for diagnosis (Nataro et al., 1998).
2.5 methoDs of treatment
EAEC infections are generally self-limiting. Considering the heterogeneity and local variations of EAEC, 
administration of antimicrobial therapy should be performed on an individual basis and according to the 
local antimicrobial susceptibility patterns. Infections are normally responsive to oral rehydration but in 
the case of persistent infection people tend to be less amenable to watery treatment alone, wherefore anti-
microbial or prophylactic measures should be considered (Kaur et al., 2010). Studies of the development 
of antibiotic resistance for EAEC have reported moderate- to high-level resistance towards ampicillin, 
tetracycline, trimetoprim, sulfamethoxazole and chloramphenicol. Susceptibility towards different types 
of antibiotics vary by geographic region (Huang et al., 2006).
Gene Description
aggR Master regulator gene of AAF and dispersin 
aafA AAF/II
astA EAST1 toxin
pet Plasmid-encoded toxin
aatA Transporter of dispersin to the bacterial surface
aap Dispersin protein central for adherence, colonization and biofilm
pic A serine autotransporter with hemoglutinic and mucinase activity; affecting colonization
shf Co-factor in biofilm formation
setBA Chromosomal encoded SheT1 toxin
fis Protein inducing transcription of AggR
yafK A protein which affects the transcription of AAF/II
tolC Chromosomal encoded efflux pump associated with aggregation
hra1 Outer membrane protein that is required in biofilm and adherence
Table 2.2 Overview of reviewed virulence genes for E. coli 042 (The Authors).
Picture 2.4  HEp-2 cell-adherence showing the aggregative 
stacked brick pattern (Huang et al., 2006).
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The infection of EAEC in humans have been shown to be responsive towards antimicrobial therapy.
The results of two specific treatments are shown in table 2.3.
Study one (Mexico, Jamaica) Study two (Mexico, Guatemala, Kenya)
Treatment
Ciprofloxacin
(n = 38)
Placebo
(n = 26)
Rifaximin
(n = 30)
Placebo
(n = 13)
Dosage 
500 mg twice a 
day for three days
Twice a day for 
three days
200 or 400 mg twice 
a day three days
Twice a day for
three days
Median TLUS (h) 35,3 55,5 22 72
Microbiological 
cure
NA NA NA NA
Table 2.3 Two studies of antimicrobial therapy against E. coli 042. The used drugs are ciproflaxin 
and rifaximin (Reviewed by Huang et al., 2006)
Figure 3.2 Life cycle of C. elegans (Wormatlas.org).
Referred to in section 3 Caenorhabditis elegans
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3. Caenorhabditis elegans
C. elegans is a small free-living soil nematode with 
a length around 1 mm. The worm grasses on micro-
organisms; mostly bacteria. It has two sexes, male 
and hermaphrodite, though the male is rare. The 
hermaphrodite produces both eggs and sperm and 
can self-fertilize, resulting in a progeny of up to 300 
worms (Altun & Hall, 2009). The body plan of the 
adult worm is unsegmented and cylindrical with 
an outer and inner tube. The outer tube consists of 
cuticle, hypodermis, excretory system, neurons and 
muscles, while the inner tube consists of pharynx, 
intestine and gonads, see figure 3.1. In the pharynx 
there is a grinder which crushes bacteria. The nervous 
system of C. elegans consists of ganglia in head and 
tail and a ventral and a lateral nerve cord, see figure 3.1 (Altun & Hall, 2009).
The worm has four larval stages, see figure 3.2. It develops into to an adult over three days, and has a 
lifetime of approximately 10-15 days. Under unfavorable life conditions the larva will go into Dauer 
stage where it is isolated from the environment for up to four months. This stage can occur when the larva 
is about to turn into the second larval stage. During the Dauer stage feeding is arrested and locomotion 
reduced for as long as the conditions are unfavourable. The lifecycle of the worm is useful in the labora-
tory, because the growth can be halted between L1 and L2 which makes the worm easy to synchronize. 
Another advantage compared to other test organisms is that the worm can be kept as frozen stocks (Hope, 
1999; Altun & Hall, 2009). In 1998 the genome sequence of C. elegans was completed as the first multi-
cellular organism (The C. elegans Sequencing Consortium, 1998).
3.1 C. elegans as a moDel to stuDy microbial pathogenesis
When treating diseases in humans and animals caused by pathogenic bacteria, it is useful to know the 
pathogenesis of the bacteria and how the host is responds to the bacteria. This is often studied in vertebrate 
animals such as mice and chickens. Additionally, some invertebrates e.g. amoeba, fruit flies and nema-
todes, are used in virulence models for pathogenic bacteria.
When C. elegans is grown in the laboratory under normal conditions, it feeds on the apathogenic E. coli 
strain OP50. The worm can be used in a virulence model for pathogenic bacteria or fungi, if the food 
source is replaced with the microbe of interest. Bacterial pathogens can kill C. elegans in two different 
ways; by slow-killing or fast-killing. Slow-killing is defined as a slow and lethal colonization of the patho-
gen in the gastrointestinal tract of the worm, while fast-killing is caused by the release of toxins from the 
pathogen (Tan et al., 1999).  
C. elegans is used in virulence models for several different bacteria. These studies show that differ-
ent pathogenic bacteria can cause death in the worm (reviewed by Ewbank, 2002). The first studies to 
make use of C. elegans as a model to investigate bacterial pathogenesis were performed in 1999. In two 
different studies C. elegans was shown to be genetically applicable to examine the pathogenesis of the 
disease-causing bacteria Pseudomonas aeruginosa (Darby et al., 1999; Tan et al., 1999). Since the first 
two studies, numerous pathogenic bacteria have been determined to be capable of infecting and killing C. 
elegans. These studies show that a broad range of pathogenic bacteria is able to kill C. elegans. Table 3 .1 
shows different bacteria, their pathogenesis and their effect on C. elegans in virulence models.
Figure 3.1 A: DIC image of an adult worm. B: Schematic 
drawing of anatomical structure (Altun & Hall, 2009).
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In a kill assay for E. coli strain 042, performed by Bhargava et al., C. elegans was used to investigate the 
importance of the heat-resistant agglutinin (hra1) gene, encoding an outer membrane protein. The hra1 
gene was inactivated in E. coli 042 which prolonged the lifetime of C. elegans compared to the wild 
type. On the basis of these results the hra1 gene was concluded as an accessory colonization factor for E. 
coli 042 (Bhargava et al., 2009). However, it is still necessary to determine the death mechanism and C. 
elegans needs to be verified as a suitable virulence model for E. coli 042.
Species Natural disease C. elegans disease Year Refs.
Escherichia coli Urinary tract infection, 
blood infection
Digestive tract
infection
2006 Diard et al.
(ExPEC)
Escherichia coli 
(EAEC 042)
Opportunistic human 
pathogen
Digestive tract
infection
2009 Bhargava et al.
Pseudomonas 
aeruginosa
Opportunistic human 
pathogen
Digestive tract
infection, toxin
1999 Darby et al.
1999 Tan et al.
Enterococcus 
faecalis
Opportunistic human 
pathogen
Digestive tract 
persistent infection 
2001 Garsin et al.
2006 Moy et al.
Vibrio cholera True human pathogen
Digestive tract
infection
2006 Vaitkevicius et al.
Staphylococcus 
aureus
Opportunistic human 
pathogen
Digestive tract
infection 
2003 Garsin et al.
Streptococcus 
pneumonia
True human pathogen Toxin 2001 Garsin et al. 
Microbacterium 
nematophilum
C. elegans pathogen Biofilm 2000 Hodgkin et al.
Salmonella 
typhimurium
True human pathogenv
Digestive tract 
persistent infection
2000 Labrousse et al.
2000 Aballay et al. 
Listeria 
monocytogenes
Opportunistic human 
pathogen
Digestive tract
infection
2006 Thomsen et al. 
Serratia 
marcescens
Opportunistic human 
pathogen
Toxin 2001 Pujol et al.
Burkholderia 
pseudomallei
Opportunistic human 
pathogen
Endotoxin 2002 Aballay & Ausubel
Table 3.1 Different bacteria and their pathogenesis in virulence models (Sifri et al., 2005).
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3.2 laboratory aDvantages of C. elegans 
Due to the short lifecycle and the fact that it is relatively easy to synchronize, C. elegans is a suitable or-
ganism for virulence models. Because the hermaphrodite self-fertilize, it is possible to work with numer-
ous genetic identical worms which increases the statistic relevance. The fact that the worm is transparent 
makes it easy to observe the anatomy and physiology of the worm. It is inexpensive to grow and feed 
the worms since they feed on bacteria. The worm does not require special facilities and they do not take 
up much space in the laboratory. Because the worm is a small and simple organism there is no advanced 
ethical discussion to deal with when exposing the worm to pathogenic bacteria. Furthermore, the fully 
sequenced genome makes C. elegans suitable for gene substitutions studies (Hope, 1999).
The double mutant C. elegans-AU37, used in this report, has a temperature sensitive mutation and a sek-1 
mutation. The wild type is called N2-bristol. The temperature sensitive mutation affects the fertility of 
the worm. At 25 °C the worm is sterile while it is fertile at 15 °C. This mutation makes it possible to syn-
chronize the worm and grow it on bacteria, without reproduction of the worm. The sek-1 mutation gives 
a defect in the MAPK pathway which reduces the effect of the immune system.
3.3 C. elegans Defense mechanisms
The use of simple organisms and mammals as virulence models can provide valuable understanding of 
general host-pathogen interactions of bacteria and other pathogens. The applicability of such models re-
garding bacterial pathogenesis in humans requires a certain extent of comparability between the immunity 
of the different hosts. It is evident that there are certain universal virulence factors present which are es-
sential for pathogenesis independent of the host infected (Mahajan-Miklos et al., 1999). C. elegans holds 
several advantages in the laboratory which, together with its completely analyzed genome, might prove 
the nematode a suitable host to determine virulence factors of bacteria (Ewbank, 2002).
The defense mechanisms of C. elegans consist of three different types of protection; behavioral response, 
physical barriers, and the innate immune system (Schulenburg et al., 2004).
Behavioral response
C. elegans is very sensitive to intraintestinal bacterial infections. Therefore it is reasonable to think that 
intact pathogens simply do not get access to the worms intestine normally (Ewbank, 2002). The physical 
behavior of C. elegans serves to avoid general encounters with pathogens. This is done by the nematodes 
ability to recognize pathogens and coordinate a behavioral reaction. It has been reported that C. elegans 
is able to sense different chemical signals including attraction towards nutrients and repulsion from toxic 
chemicals (Troemel, 1999).
Physical barriers
The anatomy of C. elegans serves to protect it from infections. Particularly the grinder in the pharynx, 
which crush bacteria by simultaneous muscle contractions, is of exceptionally importance for the worms 
defense against pathogens. The grinder prevents intact bacteria from reaching the vulnerable intestinal 
parts of the lumen (Avery, 1997).
Innate immune system
Except from vertebrates, higher organisms depend immunologically on innate immunity. The innate 
immune system of invertebrates, plants, fungi, and to some extend mammals share many similar charac-
teristics. This indicates a number of immunological factors with a common origin. These factors must have 
stayed unchanged through thousands of generations across different species (Schulenburg et al., 2004). 
The immunological parallels support invertebrate models including C. elegans as a promising tool in the 
understanding of the innate immunity in humans and vertebrates in general. This being so, C. elegans as 
a virulence model will be competent to indentify human relevant virulence factors that target components 
present in both nematodes and humans and does this in a similar way (Schulenburg et al., 2004).
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After infection by a certain bacterium the immunological reactions of C. elegans rely on its ability to 
recognize the infection as pathogenic. This can occur through pathogen-associated molecular patterns. 
Following this, C. elegans activates a number of regulatory pathways and secretes several immune effector 
molecules to handle the infection. The immune effector molecules will either kill the pathogen or reduce 
its pathogenic effect by means of detoxifying enzymes to neutralize the bacterial toxins (Schulenburg et 
al., 2004).
The innate immune system of C. elegans appears to contain four fundamental signaling pathways: p38 
mitogen-activated protein kinase (MAPK), transforming growth factor-β-like, programmed cell death and 
an insulin-like receptor (Schulenburg et al., 2004). Different studies have described involvement of these 
pathways in response against a number of pathogens. The transforming growth factor-β-like pathway has 
been reported to upregulate the production of certain lysozymes and lectins after infection of Serratia 
marcescens (Mallo et al., 2002). The MAPK-pathway is reported to be crucial for C. elegans´  resistance 
against P. aeruginosa (Kim et al., 2002) and also involved in the nematodes resistance against S. enterica 
which furthermore is reported to involve programmed cell death (Aballay et al., 2000). In addition a 
series of studies stated that the insulin-like receptor pathway is a highly contributory factor in C. elegans´ 
immunity against P. aeruginosa, E. faecelis, and S. aureus (Garsin et al., 2003). An essential part of the 
C. elegans defense against pathogens might be based on a general stress response from these pathways 
(Schulenburg et al., 2004). Consequently the survival of C.elegans is highly dependent on an efficient 
immune system. 
In spite of these arguments for the use of C. elegans, it is important to keep in mind that C. elegans only 
share very few similarities with humans. Thus, transferring results from C. elegans studies to pathogen-
esis in humans should be done very cautiously.
4. MAteriAls And Methods
In order to answer the questions mentioned in the introduction, the following experiments were conducted.
A killing assay was set up to demonstrate whether E. coli 042 is a pathogenic to C. elegans with a positive 
control in E. coli OP50. Furthermore, it was investigated whether C. elegans can be used in a virulence 
model for the pathogenesis of E. coli 042.
The pathogenesis of E. coli 042 to C. elegans was investigated by growing the worm on GFP-marked 
strains of E. coli 042 and OP50. By photo microscopy it was possible to decide whether E. coli 042 colo-
nize the intestine of the worm.  
It would be possible to investigate whether the pAA2 plasmid is essential for pathogenesis by transfer-
ring the plasmid from 042 to OP50. An indication of pAA2 virulence would be indicated by a significant 
decrease in mean life time of C. elegans when grown on transformant OP50.
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4.1 strains
The Caenorhabditis elegans strain used in this study is the double mutant AU37 obtained from Ausubel 
lab, Massachusetts General Hospital. The strain was maintained using established procedures as described 
at Wormbook.org (Stiernagle, 2006). The bacterial strains and plasmids used in the experiments are listed 
in table 4.1. Bacteria were cultured in either Luria-Bertani (LB) media or solid LB-agar at 37 °C. In ad-
dition, antimicrobials were used when appropriate in the following concentrations; ampicillin (50 µg/ml), 
kanamycin (50 μg/ml), nystatin (12.5 μg/ml).
4.2 C. elegans soliD meDium killing assay 
In order to investigate the ability of E. coli 042 to kill C. elegans an assay was set up on 5 cm solid 
Nematode Growth Medium (NGM) containing cholesterol.
Day 1 - Synchronization
Pregnant worms were harvested from a NGM plate by washing with 1 mL M9 buffer, and collected in an 
Eppendorf tube by centrifugation at 1000 G for 1 min. Subsequently the worms and eggs were settled as 
a small pellet and the supernatant was removed. Thereafter the embryos were isolated by treatment with 
1mL bleach solution (685 µL Milli-Q, 65 µL 15 % NaOCl, 250 µL 2N NaOH). The embryos were re-
leased after 5-10 min. when the solution was clear and no worms visible. After centrifugation at 1000 G in 
Table 4.1 Overview of utilized plasmids and bacterial strains in the experiments (The Authors).
Bacterial 
strain
Characteristics and/or 
application
Antibiotic  
resistance 
Reference/source 
E. coli 042
Wild type. Pathogenic 
E. coli strain used in kill 
assay
Chloramphenicol SSI strain collection
E. coli OP50
Apathogenic E. coli strain 
used for C. elegans main-
tenance
SSI strain collection
E. coli DH5αλpir
Host strain for pSW29T 
plasmid
Kanamycin SSI strain collection
Plasmid
Characteristics and/or 
application
Antibiotic  
resistance 
Reference/source 
pSW29T
Suicide plasmid which 
had the desired antibiotic 
resistant. Pir dependent 
for replication
Kanamycin 
Extracted from 
DH5αλpir
pAA2
Plasmid situated in E. coli 
042 presumably causing 
pathogenesis of 042
Extracted from E. 
coli 042
pBAD18-GFP
0.2 % arabinose is neces-
sary in agar to produce 
GFP
Ampicillin
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1 min. the embryos were collected. The supernatant was removed and the embryos washed 3 times with 1 
mL M9 buffer in order to make sure that all bleach solution was removed so the embryos would survive. 
Embryos were allowed to hatch over night at 15 °C in 250 μL M9 buffer.
Day 2 - Seeding of C. elegans
The hatched L1 larvae in the Eppendorf tube were collected by centrifugation at 1000 G for 1 min. The 
supernatant was removed and the L1 larvae were transferred to two NGM plates seeded with E. coli OP50. 
The plates were incubated for two days at room temperature. 
Day 3 - Preparation of overnight culture
Overnight culture of E. coli 042 and E. coli OP50 were inoculated in 5 mL of LB with a colony from each 
and lastly incubated at 37 °C over night.
Day 4 - Seeding of C. elegans on E. coli 042 and OP50
Overnight culture of E. coli 042 and OP50 were harvested and resuspended in 100 µL M9 medium and 
plated on NGM plates. Half of the plates were treated with nystatin to avoid fungal contamination. All the 
plates were incubated 4-5 hours at 37 °C. The L1 larvae from day 2 have developed into synchronized L4 
adult worms. The plates were washed with 1.5 mL M9 buffer, and the worms were collected by centrifu-
gation at 1000 G for 2 min. The worms were washed 3 times with M9 buffer and resuspended in 0.5 mL 
M9 buffer. The NGM plates with E. coli 042 and OP50 were cooled to room temperature and seeded with 
approximately 40 synchronized worms. The plates were incubated at 25 °C.
Day 5 - Killing assay with C. elegans
The plates were scored for dead worms every 24 hours. A worm was considered dead and removed if it 
failed to move after gentle touch with a wormpicker (platinum wire).
4.3 pathogenesis of e. Coli 042 by gfp
GFP can be used to measure live bacteria in the intestine of C. elegans and thereby picture the colonization 
of the worm. Because GFP exported out of the cytosol of E. coli fails to fold up in an active conformation 
it is undetectable with a fluorescent microscope and thus the microscope will only detect fluorescence 
emitted from live cells accumulated in the worm (Feilmeier et al., 2000).
The plasmid pBAD18-GFP that is under control of an arabinose promoter was transformed into E. coli 
strains 042 and OP50. The GFP-marked strains are hereafter designated 042-GFP and OP50-GFP. A con-
centration of 0.2 % arabinose is needed for the plasmid to produce GFP protein. 
This experiment was setup as described in section 4.4.6 Electro competent cells, with the exception that 
GFP-marked strains of E. coli 042 and OP50 were used. The GFP kill assay was carried in the same 
manner as the regular kill assay, described in section 4.2 C. elegans solid medium killing assay. The 
bacteria were grown on NGM plates containing ampicillin since the plasmid pBAD18-GFP encodes am-
picillin resistance. After the worms have grown on NGM plates seeded with GFP-marked E. coli strains, 
they were ready for photo microscopy. In order to prepare the worms for GFP pictures they were washed 
of the plates with M9 buffer and further washed 3 times to extensively remove attached bacteria. Most of 
the supernatant was removed and soaked in 0.7 % NaN3 to immobilize the worms. Additionally, a 1.5 % 
agarose mixture was prepared and plated out on microscope slides and topped with another slide to make 
the gel planar. When the gel was dry the top microscope slide was removed and the worms placed on top 
of the gel. Lastly a cover glass was put on top. Subsequently, pictures were taken on an Olympus BX61 
microscope with an Olympus DP71 digital camera.
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4.4 transformation of e. Coli op50 with paa2 from e. Coli 042
To study the virulence of the pAA2 plasmid in E. coli 042 it is attempted to transform pAA2 into E. coli 
OP50. To select only bacteria that have taken up the pAA2 plasmid, a marker to follow pAA2 is required. 
The suicide vector pSW29T encoding kanamycin resistance is used to transfer kanamycin resistance into 
pAA2 as the marker. This is done by selecting a homolog region on pSW29T and pAA2.
4.4.1 Objectives and experimental outline with flowchart
1.	 A 600bp large 
region just upstream of 
the aat gene cluster was 
PCR amplified from 042. 
 
 
 
 
2.	 pSW29T is puri-
fied from host E. coli 
DH5αλpir. 
 
 
 
 
3.	 600 bp is cloned 
into BamHI site on 
pSW29T. 
 
 
 
 
 
4.	 The clone 
pSW29T-600bp-aat-
up is transferred into 
electro competent E. coli 
DH5αλpir. 
 
 
 
 
 
 
 
1.                                                                               E. coli 042
Chromosomal
        DNA
600 bp
aat - up
2.
pSW29T
kanamycin 
reistens
E. coli  DH5αλpir
3.
4.
pSW29T
E. coli DH5αλpir
pSW29T -600bp-aat - up
pAA2-Plasmid DNA
600bp 
aat-up
600bp 
aat-up
Figure 4.1 Flowchart of plasmid transformation (The Authors).
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5.	 Transformation of E. 
coli 042 with pSW29T-aat-
up. 
 
 
 
 
6.	 Recombination of 
pSW29T and pAA2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.	 Transformation of 
E. coli OP50 with pAA2-
pSW29T.
 
4.4.2 Objectives
A fast preparation of E. coli 042 is made to destroy enzymes and break down cell membranes. A PCR of 
DNA from 042 is prepared in order to amplify the 600bp-aat-up region. The 600bp region is then puri-
fied. An overnight culture of DH5αλpir containing the plasmid pSW29T is prepared and then purified 
in order to collect the plasmid. The suicide plasmid pSW29T requires Pir protein produced in E. coli 
DH5αλpir bacteria for transcribing its origin. pSW29T and the 600bp region are cut with the restriction 
enzyme BamHI. pSW29T and the 600bp region are ligated. The clone containing pSW29T and the 600bp 
insert is called pSW29T-600bp-aat-up. pSW29T-600bp-aat-up is transferred into electro competent E. 
coli DH5αλpir without the pSW29T plasmid. The culture is grown for 1.5 hours and plated on kanamy-
cin to select for transformants. A new culture is made from one emerging colony. Uptake of the 600bp 
insert is verified by PCR and gel electrophoresis. The cloned plasmid is then purified from the emerging 
 
1
4
7.
5.
pSW29T-600bp - aat - up
pAA2
E. coli 042
pAA2
pSW29T-600bp - aat - up
6.
4
3
1
pAA2 - pSW29T
E. coli  OP50
 kanamycin
resistens
3
2
2
Figure 4.2 Flowchart of plasmid transformation (The Authors).
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colony. pSW29T-600bp-aat-up is transformed into electro competent E. coli 042. Because of the ho-
mologous piece, recombination can occur. pSW29T will thus be inserted into pAA2. The transformation 
culture of 042 is incubated for 1.5 hours and plated on kanamycin to select the recombinant plasmids. 
Emerging colonies contain the recombinant plasmid pAA2-pSW29T. An emerging colony is transferred 
to a new plate and then an overnight culture of an OD between 0.6 - 0.8 is made. The pAA2-pSW29T 
plasmid is purified from the overnight culture. pAA2-pSW29T is transferred into electro competent E. 
coli OP50. The culture is plated on kanamycin to select for pAA2-pSW29T. An overnight culture of the 
transformant E. coli OP50 was prepared and worms were seeded. This assay can reveal that the virulence 
factors are on the plasmid, if the worms grown on transformant E. coli OP50 are killed faster than worms 
grown on ordinary E. coli OP50.
4.4.3 Extraction and purification of plasmid DNA
When extracting plasmids following kits were used:
 QIAprep Spin Miniprep Kit (Qiagen): For minor preparations of small plasmids.
 Qiagen Plasmid Midi Kit (Qiagen): For larger scale isolation of small plasmids and cloning.          
 Plasmid Mini AX (DNA-Gdansk): For the purification of large plasmids.
The preparations were performed on overnight cultures in appropriate amounts. All procedures were per-
formed according to the manufactures instructions.   
4.4.4 Transformation
In order to transfer genetic material, electro competent cells were used. By using electroporation the cells 
were able to take up the desired plasmid. 
4.4.5 Electro competent cells
The strains E. coli DH5αλpir, 042 and OP50 were all subject to electro-transformation. The standard pro-
cedure was to dilute an overnight culture 1/100 in 100 mL fresh LB media and incubate at 37 °C until 
exponential growth (OD600 0.6 - 0.8). Hereafter the mixture was incubated on ice for 30 min. After this 
procedure the culture was kept on ice at maximum 4 °C. The mixture was then centrifuged and the su-
pernatant discarded. The remaining pellet was washed in ice water 3 times. Finally the supernatant is dis-
carded and the pellet is resuspended in ice water to make a viscous cellular suspension. 1 μL of a relevant 
DNA mixture and 40 μL electro competent cells are placed in a precooled electroporation cuvette before 
briefly shocking them with an electric impulse (~ 2,5 kV for approx. 5 ms, Pulses Micro electroporator, 
Bio-Rad). Immediately after they are sucked from the cuvette and incubated in 2 mL Eppendorf tubes for 
1.5 hour at 37 °C. The Eppendorf tube contained conventional SOC media in order to facilitate the recov-
ery of the cells. Transformants were plated on LB agar plates with appropriate antibiotics. 
4.4.6 PCR Procedure
PCR was used to amplify purified plasmids and DNA preparations. Reaction volumes containing 
HotStarTaq® master mix were handled according to the manufacturer, see table 4.2 left. PCR were carried 
out on a DNA Engine Dyad® Peltier Thermal Cycler (MJ Research), see table 4.2 right. Afterwards 
PCR products were controlled by gel electrophoretic visualization. Supplementary use of PCR products 
was in correlation with removal of reaction constituents by illustra™ GFX™ PCR DNA and Gel Band 
Purification Kit (GE Healthcare). 
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4.4.7 Oligonucleotide primers used in PCR
Primers used in order to amplify a specific portion of 600 bp from the pAA2 plasmid are listed in table 4.3. 
4.4.8 Gel Electrophoresis
Gel electrophoresis was used in order to separate and visualize plasmids and DNA products according to 
molecular size. The different products used in the procedure is listed in table 4.4.
4.4.9 Ligation 
Ligation reactions were conducted with Fast-Link™ DNA Ligation Kit (EPICENTRE Biotechnologies) 
as directed by the manufactures protocol. For making the ligation reaction both pSW29T and the plasmid 
portion, 600bp-aat-up, were cut with the commercially available restriction enzyme BamHI (New England 
Biolabs).
The ligation mixture consisted of vector DNA and insert-DNA in a molar ratio of 1/3 estimated from a gel 
combined with procedures from the manufacturer; 1.5 μL 10X Fast-Link Ligation Buffer, 1.5 μL 10 mM 
ATP, 4 μL Milli-Q and 1 μL Fast-Link DNA Ligase adding up to a total reaction volume of 15 μL. The 
mixture was incubated for 5 min. at room temperature and transferred to 70 °C for 15 min. to inactivate 
the Fast-Link DNA ligase.
Action Time Temp.
Initial activation of 
the HotStarTaq DNA 
Polymerase
15 min. 95 oC
Denaturation 0,5 min. 94 oC
Annealing 1 min. 52 oC
Elongation 1 min. 72 oC
Number of cycles 30 times
Final elongation 7 min. 72 oC
Component
Volume/reac-
tion
HotStarTaq Master Mix 25 µL
Primer A (aat-up UP) 1.5 µL
Primer B (att-up DW) 1.5 µL
MilliQ (H20) 20 µL
Template DNA 2 µL
Total volume 50 µL
Table 4.2 Left: Components of PCR solution. Right: Settings for PCR reaction (The Authors).
Primer Purpose Sequence
aat-up UP* Amplifies a portion of 600bp 
of the pAA2 plasmid
5'-gatacaggatccgagacgtttggaggtgtatg-3'
aat-up DW* Amplifies a portion of
the plasmid, pAA2
5'-gatacaggatccgaggagtttaaagttgaagc-3'
Table 4.3 Primers used in PCR reaction. Base regions marked in red depicts the BamHI recognition site. Primers 
derived from this study was ordered from Eurofins MWG Operon.
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Product Action Manufacturer 
SeaKem ® GTG ® Agarose
Two different dilutions of agarose gel were 
used. Fragments and small plasmids were 
separated by 0.8 % agarose gels for 45-60 
min. at 50 V Large plasmids were electro-
phoresed by 0.5 % agarose gels for 1 hour 
at 25 V or 50 V 
Lonza
MassRuler™ DNA Ladder 
Mix 
The ladder mix (100bp - 10,000kb) was 
used as a marker for linear products
Fermentas
GelRed™ Nucleic Acid Gel 
Stain
The gels was subsequently died with GelRed 
™ in order to visualize the bands
Biotium
1xTAE-buffer (50xTAE 
stock, 1 l; 242g Tris base, 
57.1ml glacial acetic acid, 
100ml 0.5 M EDTA, pH 7.8)
To facilitate the migration of the DNA mate-
rial the gel was run in a1xTEA buffer
SSI
UV Illuminator/Camera
To visualize the bands a camera and UV il-
luminator from Bio-Rad
Bio-Rad
Table 4.4 Components used in gel electrophoresis (The Authors).
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5. results
Results gathered through this study are divided into three sections; C. elegans as a virulence model, the 
pathogenesis of 042 through GFP labelling, and the virulence of the pAA2 plasmid respectively. Results 
are elaborated in order to establish an understanding of the data. Additional discussion of the results will 
be processed in section 6 Discussion.
5.1 C. elegans killing assay
C. elegans was tested as a virulence model for E. coli 042 by grassing on E. coli OP50 and 042 respective-
ly. The mechanism of pathogenesis in C. elegans caused by E. coli 042 was investigated by GFP-marked 
bacteria. A small kill assay with only 4 plates were originally tested, but due to contamination by fungi and 
Micrococcus luteus the assay was terminated and data discarded. Therefore nystatin and ampicillin were 
added to avoid contamination in the following assay. A total of 18 plates were used in the assay; 10 were 
treated with nystatin, all 042 treated with ampicillin.
In order to analyze the survival curves obtained from the killing assay the program GraphPad Prism was 
used. GraphPad Prism is used to calculate basic biostatistics. We use the Kaplan-Meier method to distin-
guish between an event or no event in our experiments; interpreted as the death of a worm or no registra-
tion. The benefit of using Kaplan-Meier in biostatistics is the ability to censor data. Particularly right-cen-
soring, where a data point (e.g. a worm) is above a certain value (alive) but it is unknown by how much. 
We do not know how alive the worm is and do not wish to discriminate based on that factor. Consequently, 
we differentiate only between dead worms and non-dead worms (censored). GraphPad Prism compares 
survival curves by two methods; the log-rank test also called the Mantel-Cox test and the Gehan-Breslow-
Wilcoxon test. Only when comparing exactly two curves is the Gehan-Breslow-Wilcoxon test used, other-
wise the log-rank test is used. This is due to the nature of the Gehan-Breslow-Wilcoxon test, which is only 
for comparing two curves. The end time of the assay was determined by the death of the last worm. Each 
time step is equal to one day. Since the study ends with the last living worm, the assay will not be biased 
by uncounted living worms after the assay has ended. We are testing the null hypothesis that the survival 
curves are identical in the overall populations. In other words, the null hypothesis is grassing on different 
bacteria for C. elegans does not change their survival rate.
A total of 18 plates with grassing C. elegans 
were tested. 9 plates with OP50 as food source 
and 9 with 042. The data obtained through the 
killing assay is shown on graph 5.1.
Graph 5.1 visualize the difference in the lifes-
pan of C. elegans feeding on E. coli 042 and 
OP50. The virulence of 042 is reflected in the 
reduced lifespan of C. elegans. This further-
more proofs C. elegans as a potential viru-
lence model for 042. By comparing all graphs 
of OP50 and 042 respectively it is concluded 
that there is a significant difference in survival 
rate. Thereby we are able to state that E. coli 
042 has a pathogenic effect on C. elegans. 
The first dead worms were scored after 4 days. 
Generally worms grassing on 042 dies faster 
compared to OP50. The last worm dies after 20 
days on OP50 while the longest living worm Graph 5.1 Comparison of all the survival curves for E. coli OP50 
(green) and 042 (red) in the kill assay (The Authors).
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survives 14 days on 042. Compared to other studies this is considerable longer (Altung & Hall, 2009). 
Why we experience a longer lifespan is unaccounted for. Besides having a shorter lifespan it is worth 
noting that most worms grassing on 042 die faster throughout the entire assay. Apart from the apparent 
statistical difference between the virulence of 042 and OP50 the two worm groups also behave differently 
in the laboratory. While activity for worms on OP50 remained high for up to one week, there were already 
signs of bluntness after a few days for worms on 042. Most of the worms that grassed on 042 actually sur-
vived for a long period but were weakened. It required up to several touches with the wormpicker before 
a reaction was observed. Furthermore, it was easy to see how worms on OP50 remained inside the area 
with seeded bacteria while worms on 042 quickly were scattered around the plates. This could presumably 
also result in more worms on strain 042 gettting stuck on the sides of the Petri dishes. The stuck worms 
were observed but not scored in the assay. Why more worms fled the 042 plates are not well understood 
but one possibility could be that they were able to sense an unpleasent effect resulting from the pathogenic 
bacteria in spite of their simple physiology.
To ensure statistical significance two representative curves for worms grassing on E. coli OP50 and 042 
were compared. Two curves with representative medians and equal conditions were selected as standard 
of reference.
Graph 5.2 shows two 
curves representing the 
experiments for E. coli 
042 and OP50. Both 
graphs are positioned in 
the middle area of the 
total graph collection 
which is why we con-
sider them as representa-
tive for the respective 
bacterial groups. Each of 
the two bacterial groups 
were tested not to be sig-
nificantly different when 
comparing curves within 
the respective groups. 
The graphs and statisti-
cal data are shown in 
appendix I. The medians 
for 042 range from 
6.0-8.5 days with a mean 
value of 6.9. For OP50 
the interval is 9.0-11.0 days with a mean value of 9.7. Owing to those results we select a survival curve 
from the 042 set with a median equal to 7.0 and a curve from OP50 with a median at 9.5. The median 
can be interpreted as LT50 which is the time when half of the worms are dead. C. elegans grassing on the 
OP50 II plate is regarded as being representative for the total OP50 assay, in spite of the survival of only 
one worm from day 18 to 20. The two representative graphs are significantly different which confirms the 
virulence of  E. coli 042.
Graph 5.2 Two representative curves for 042 (red) and OP50 (green). P-value < 0.0001. 
The circled area indicates longing of the graf by just one worm. 042 median = 7.0. OP50 
median = 9.5 (The Authors).
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In order to assess the possible influence of GFP-marked bacteria and nystatin treated agar plates on the 
kill assay, these variables were mutual compared for OP50 and 042 respectively.
Figure 5.1 A shows five curves including three GFP-marked and two normal E. coli 042 plates with 
grassing worms. All five curves show similar pattern of survival throughout the entire period without any 
significant deviation. This is confirmed by GraphPad Prism which does not find any significant difference. 
Figure 5.1 B GFP-marked OP50 and normal OP50 are tested on C. elegans. The curves display a similar 
pattern of survival throughout the entire period. GraphPad Prism does not report any significant differ-
ence. 
 
Figure 5.1 C shows five curves including three plates with nystatin and two without. All plates are with E. 
coli 042. Compared to figure 5.1 A, B, and D there is a greater variation in the pattern of survival within 
the dataset. The two curves with a higher median was treated with nystatin which could be the reason for 
the observed deviation, though no significant difference is reported by GraphPad Prism.
Figure 5.1 A: comparison of GFP-marked 042 and normal 042. B: comparison of GFP-marked OP50 and normal OP50. C: 
comparison of nystatin treated 042 and normal 042. D: comparison of nystatin treated OP50 and normal OP50 (The Authors).
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Figure 5.1 D shows three OP50 curves with nystatin and two curves without. The graphs exhibit the same 
pattern of survival throughout the entire period and do not differ significantly from each other. GraphPad 
Prism indicates no significant difference between the graphs.
None of the four graphs on figure 5.1 show significant difference. Because the graphs do not differ sig-
nificantly it is possible to conclude that GFP marking and the addition of nystatin are variables that do 
not affect the data set. By letting C. elegans grass on E. coli 042 and OP50 it was concluded that 042 is 
pathogenic and reduces the lifespan of C. elegans significantly when compared to OP50. By comparing all 
of the data, obtained from the assay with OP50 and 042, a significant difference in survival was proven.
5.2 gfp-markeD e. Coli strains in vivo
Graph A and B in figure 5.1 have been included to emphasize that the GFP strains have not affected the 
survival of the worm noticably. The survival curves from GFP strains of E. coli 042 and OP50 do not 
differ from survival curves of normal strains of E. coli 042 and OP50. This justifies the use of the GFP-
marked strains to investigate the pathogenesis of E. coli 042.
C. elegans was grown on a lawn of E. coli 042-GFP and OP50-GFP and pictures were taken on an 
Olympus BX61 microscope with an Olympus DP71 digital camera. This resulted in pictures of the worm 
and pictures of the fluorescence emitted from the worm. The two different pictures were superimposed 
to give a combined picture of the worm with the fluorescence displaying colonized bacteria in the worm. 
Picture 5.1 shows two worms exposed to E. coli 042-GFP and OP50-GFP for 7 days. 
Colonization is observed in C. elegans exposed to E. coli 042-GFP. Massive colonization is apparent near 
the grinder and in the rest of the intestine of the worm. There is a distinct difference when compared to 
E. coli OP50-GFP, where few live bacteria are present in the intestine of the worm without colonization. 
Picture 5.1 Left: Colonization of E. coli 042-GFP in C. elegans. Right: Colonization of E. coli OP50-GFP in C. elegans. The 
pictures show worms that have been exposed to OP50-GFP and 042-GFP from the age of 2-9 days - a total exposure of 7 
days (The Authors).
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To further investigate the onset of colonization pictures of worms were taken after 4 days, see picture 5.2.
Pictures taken after 1 day did not show any emitted fluorescence from ingested bacteria and therefore no 
colonization. This is because E. coli does not accumulate in the intestine of C. elegans during the first 
days. This might be caused by the effectiveness of the grinder which crushes the bacteria. The worms 
exposed to E. coli 042 were transferred to a lawn of E. coli OP50. This resulted in recovery of the worm 
(data not shown). Therefore we suggest that the infection with E. coli 042-GFP was not persistent.
Picture 5.2 Left: Colonization of E. coli 042-GFP in C. elegans. Right: Colonization of E. coli OP50-GFP in C. elegans. The 
pictures show worms that have been exposed to the E. coli OP50-GFP and 042-GFP from the age of 2-6 days - a total expo-
sure of 4 days. The burst on the worms is due to a gonadal mutation (The Authors).
5.3 transformation of e. Coli op50 with paa2-psw29t
The objective of the experiment was to transfer the pAA2-pSW29T plasmid from E. coli 042 into E. coli 
OP50. This was attempted by the use of the suicide vector pSW29T which requires the initiation protein 
Pir for replication. The PCR amplified fragment of 600bp from the aat-up region of pAA2 was cut with 
the restriction enzyme BamHI and inserted into the suicide vector pSW29T. pSW29T and the 600bp frag-
ment were ligated. The clone pSW29T-600bp-aat-up was veryfied by gel-electroforesis and illustrated in 
figure 5.2. The band in lane 2 displays the closed ring plasmid pSW29T-600bp-aat-up. The bands in lane 
3 display the cloned plasmid pSW29T-600bp-aat-up cut with BamHI. The band at 2550bp displays the 
linear pSW29T-600bp-aat-up. The band at 1900bp displays the linear plasmid without the 600bp frag-
ment. The  band at 600bp is the 600bp insert cut out of pSW29T-600bp-aat-up.
It was not possible to transfer the kanamycin resistance into electro competent E. coli 042. Therefore it 
was not possible to continue the experiment and eventually get the E. coli OP50 with the pAA2-pSW29T-
aat-up plasmid to investigate the role of pAA2 in pathogenesis. The possible reasons for why the transfer 
of kanamycin resistance did not succeed are addressed in section 6 Discussion.6. Discussion
|  MAY 2010 |RUC | Dept. of SCienCe, SyStemS anD moDelS © 2010 the authors
page 31
Figure 5.3 Lane 1 is the ladder. Lane 2 displays the closed circular plasmid pSW29T-600bp-aat-up. Lane 3 displays the 
cloned linear plasmid pSW29T without the 600bp-aat-up reagion cut with BamHI. The 3 bands in lane 3 represents pSW29T, 
pSW29T with the 600bp insert and lastly the 600bp insert alone (The Authors).
Figure 5.2 Location of selected genes, restriction sites and our 600bp-aat-up region on pSW29T-600bp-aat-up (The Authors).
2550bp
1900bp
600bp
1       2     3 
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6.1 C. elegans as a virulence moDel
The results of the C. elegans killing assay show that worms living on E. coli strain 042 die significantly 
faster compared with the worms living on OP50. Likewise, there is also a significant difference between 
OP50 and 042 when the worms were grown on nystatin treated agar plates and when E. coli were GFP-
marked. In addition, it is worth noting that the different OP50 killing assays were not significantly dif-
ferent from each other in any case. The same was valid for the 042 killing assays. Thus, the killing assay 
demonstrate that C. elegans is suitable to model the virulence of E. coli strain 042.
The C. elegans mutant used in our experiments has a defective MAPK-pathway. As stated earlier, the 
MAPK-pathway is one of four fundamental signaling cascades of the C. elegans’  innate immune system 
(Schulenburg et al., 2004). Furthermore, the MAPK-pathway is claimed to be present in both humans 
and C. elegans. The MAPK-pathway, which is common for different organisms, is a central part of the 
immune response and in the physiological response towards cellular stress. It might be a long-established 
component of the innate immune system with a pronounced evolutionary influence (Irazoqui & Ausubel, 
2010). To assess the impact of the defective MAPK-pathway it would be of interest to replicate this study 
using the wild type C. elegans N2-Bristol.
Further studies are needed to determine and analyze the specific virulence factors of E.coli strain 042 
involved in the pathogenesis towards C. elegans. So far, the hra1 gene is the only factor known to be 
specifically involved in E. coli 042 pathogenesis against C. elegans (Bhargava et al., 2009). Until more is 
known about the complex host-pathogen interactions it is difficult to assess the potential of C. elegans as a 
model to study specific virulence factors in E. coli 042. Yet, several studies have used C. elegans as a viru-
lence model to study defense mechanisms, e.g. the innate immune system, using a broad range of differ-
ent Gram-positive and Gram-negative bacteria (reviewed by Ewbank, 2002). Some of these experiments 
suggest that there are certain similarities among the processes of the C. elegans’  innate immune system 
and that of mammals (Schulenburg et al., 2004). This indicates that C. elegans might prove to be a suit-
able model in the investigation of some parts of bacterial pathogenesis in humans and thus might provide 
useful knowledge in the development of novel antibacterial strategies (Irazoqui & Ausubel, 2010).  
There are obviously immense physiological differences between humans and C.elegans. This makes it 
difficult to apply the virulence factors that are observed in the C.elegans model, directly to human patho-
genesis. This is a drawback of the C.elegans model but the pathogenesis that is observed in the worm 
could hypothetically be the same as the early stages of pathogenesis that occur in humans. As an example, 
the mode of colononization could presumably be similar in both humans and C.elegans. A further in-
vestigation of this hypothesis could be made by inspecting the infected worms to see if a stacked brick 
pattern and biofilm formation are present. Furthermore, there might be several steps in the early immuno-
logical processes in which there exist similarities among C. elegans and humans. Thus, we still consider 
C. elegans as an appropriate model to study bacterial pathogenesis of E. coli 042 and that the nematode 
might give valuable information in the treatment of this pathogen.
6.2 plasmiD assay
Unfortunately, construction of the OP50 transformants, that were supposed to clarify whether the patho-
genesis was mediated by the genes on the pAA2 plasmid, failed. Insert of the homologous region of pAA2 
into the suicide vector pSW29T was successful and verified by gel electrophoresis. 
Despite several attempts we were not able to grow any OP50-pAA2-pSW29T bacteria on the selective 
plates with kanamycin. This is most likely because the 042 did not take up the pSW29T-600bp-aat-up 
plasmid or that the recombination between the two plasmids did not occur. There could be several reasons 
for this; one being that the plasmid for some reason was not taken up by 042 despite the fact that electro-
shock was used which is a widely accepted method for the uptake of plasmids. This could be attributed to 
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the 042 strain which might be particularly deficient when taking up plasmids, although it is a hypothetical 
suggestion. One way of improving the method could be to increase the concentration of plasmids since 
the use of electro competent cells give a relative small yield of transformants. In principle only one bac-
terium is required to take up the plasmid for the transformation to occur but because the probability of 
recombination is rather low, a lot of transformants are required to increase the chance of recombination.  
If the plasmid was absorbed, it would have to recombine with the pAA2 plasmid to ensure that it was repli-
cated together with the bacterium. This is due to the fact that the 042 strain does not produce the Pir protein 
which is required for the pSW29T to replicate. The recombination could be hampered because the 600bp 
homologous region might be of insufficient length to facilitate recombination. Therefore, it could be helpful 
to increase the size of the homologous region without interfering with essential genes. Otherwise, it could 
help to change the homologous region to another locus on the plasmid which might have improved homol-
ogy. Furthermore, a putative reason for the lack of recombinants could be that the homologous region had 
partial homology with another region of the plasmid which could interfere with the recombination process. 
Yet another reason for the fact that we do not see any colonies on our selective plates could be that the 
kanamycin coding gene was somehow disrupted or for some reason could not function in the 042 strain. 
This would not allow for bacteria to grow even if they had taken up the pSW29T-600bp-aat-up plasmid 
and recombined, because the kanamycin would obstruct the growth. 
If the experiments had been successful in constructing OP50 transformants which had taken up the pAA2-
pSW29T plasmid it could have made a significant contribution to understanding the pathogenesis of E. 
coli 042. This would require that we had been able to show a significant difference between the survival 
of the worm on OP50 with pAA2-pSW29T and standard OP50. If this had succeeded it would greatly 
enhance the possibilities of constructing successful mutagenesis studies because the amount of DNA that 
was to be examined was limited to the pAA2 plasmid. Studies using OP50 with pAA2-pSW29T could 
thus help identify a more specific role of different genes in pathogenesis and thereby reveal potential 
targets for treatment with a greater degree of certainty. 
6.3 pathogenesis
In order to assess the full impact of EAEC, in particular the 042 strain, as a human pathogen the different 
genes encoding virulence has been evaluated. When reviewing the litterature throughout this report there 
is a common understanding that the pathogenesis of EAEC is a three step model consisting of adherence 
and colonization, biofilm formation and finally toxin secretion together with inflammation. This appears 
to be a sequence of events that occur chronologically whenever pathogenesis is seen, although it obvi-
ously requires that the genes responsible for mediating the different steps are present. Even though the 042 
strain contains several genes that encode toxins there are no apparent indications that these were secreted 
in our assay, mainly because we observe slow-killing. Another reason for the observed slow-killing could 
be that the toxins are secreted but does not affect the worm to a degree where it is observable in our assay. 
Slow-killing has in other studies been suggested to be caused by colonization of the intestine and thereby 
ascribes a minor or irrelevant role of toxin secretion as the mediator of slow-killing (Tan et al., 1999; 
Moy, et al., 2006). Other studies have shown fast killing in C. elegans within a matter of hours and have 
attributed this to toxin secretion (Tan et al., 1999). When slow-killing is observed in our assay it is obvious 
to designate it to colonization. Since the fast-killing in other studies was achieved under very different 
conditions it is hard to give a definite answer or differentiation as to which steps are responsible for the 
killing of C. elegans. One fact that was very different in a fast-killing assay was the use of peptone- 
glucose-sorbitol agar which is more nutritious compared to NGM. This could have an effect on the toxin 
secretion of the bacteria since the pic gene, located on the opposite strand right across from the setBA 
gene, has been shown to increase expression in high nutritious media at 37 °C (Behrens et al., 2002). 
Since the two genes are located close to each other it is plausible to think that their transcription could be 
connected which could result in a higher expression of the setBA at 37 °C as seen in the human intestines. 
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This could indicate a putative role of ShET-1 in pathogenesis even though there are limited indications of 
this in our assay. Since our assay does not mimic the conditions bacteria experience when infecting the 
human gastrointestinal tract there are limitations with respect to giving an accurate interpretation of the 
pathogenesis in humans. This could be a drawback when using C. elegans since it is not able to thrive at 
37 °C where most bacteria have favorable growth conditions. This could result in different gene expres-
sions dependent on the temperature and could give an incomplete understanding of the genes mediating 
pathogenesis when using the C. elegans model. 
There are certain suggestions that point toward the fact that colonization is the key mediator in the killing 
of C. elegans in our assay. Furthermore, this is consolidated with the GFP pictures which show a clear dif-
ference between the amount of bacteria that colonize the intestine of the worms infected with GFP-marked 
042 and OP50 strains. The GFP-marked 042 show extensive colonization throughout the intestinal tract. 
This is no undisputed proof since it does not confirm that toxin secretion is not taking place simultane-
ously, but makes it conceivable to think that this degree of colonization severely weakens the worm and 
eventually leads to death. Furthermore, the high degree of colonization obviously means that there are 
numerous bacteria in the intestine of the worm. If it can be assumed that toxin secretion is proportional to 
the number of bacteria, the release of toxins should presumably occur at a rather low rate in our kill assay 
because we do not observe fast-killing which is associated with toxin secretion.
Furthermore, it should be noted that virulence genes, which often are nonessential for growth, will only 
be expressed under special conditions. Therefore it could improve the assay if the bacteria were grown 
on DMEM media, which has been suggested to induce transcription of aggR (Imuta et al., 2008). This 
could enhance the transcription of several virulence genes including aafA and aap which would result in 
increased expression of AAF/II and dispersin. This would probably make the adherence and colonization 
even more distinctive and could give rise to an earlier onset of colonization. In consequence of this, a 
more pronounced difference between the lifespan of worms, grassing on the different bacterial strains, 
would probably be observed due to the fact that the death mechanism is mainly attributed to colonization. 
A reason for the extensive colonization that we observe on the GFP pictures could be an age related im-
pairment of the grinder responsible for crushing live bacteria. This would allow for more live bacteria to 
reach the intestines in older worms which could lead to colonization. The pictures in our assay were taken 
on 6 and 9 days old worms. The greatest degree of colonization was observed in the youngest worms, sug-
gesting that impairment of the grinder was not the reason for the observed difference in survival, between 
the worms feeding on the different strains. This issue was furthermore circumvented by synchronizing 
the worms so there was no difference in age between the worms grassing on OP50 and 042. This should 
minimize the uncertainty to an extent where it should be considered to be of very little importance. 
As part of our killling assay C. elegans was grown on the 042 strain for some days before transferring it 
back to OP50 to see if the colonization would persist after the transfer. This indicated that the colonization 
was not persistent, although the observations were inconclusive. It could suggest that repeated exposure 
to 042 is required for the colonization although repeated trials are necessary to confirm this hypothesis.
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7. conclusion
It is shown that E. coli 042 is pathogenic to C. elegans AU37. The worm is demonstrated as a suitable 
virulence model for E. coli 042. In addition it is shown by photo microscopy, that the E. coli 042-GFP 
colonize the intestine of C. elegans. The colonization by 042 is assumed to be the reason for the signifi-
cantly faster killing of the worm in these assays. Transfer of the pAA2 plasmid to E. coli OP50 did not 
succeed. Additional studies are necessary to investigate the role of pAA2 in the virulence of E. coli 042 
and its part in the complex host-pathogen interactions.
7.1 future prospects
To investigate the exact role of colonization, and cause of death in the worm, it is possible to perform 
genetic analyses of the gene expression in C. elegans. This can be done by silencing the gene of interest 
using RNA interference by feeding C. elegans with E. coli expressing double-stranded RNAs correspond-
ing to C. elegans genes (Irazoqui & Ausubel, 2010). In this way it is possible to analyze the expression 
of different genes in the worm and their influence on the defense mechanism against different pathogens. 
C. elegans might be used to study immunological mechanisms in higher organisms, including mammals, 
because of the evolutionary conservation of some innate host defence mechanisms against microbes and 
bacterial virulence mechanisms (Irazoqui & Ausubel, 2010).
Another promising application of C. elegans is the potential to investigate new ways of treating infections 
caused by EAEC. One way could be development of compounds that specifically inhibit AggR since this 
has proven to be the single most important regulator of genes essential in virulence. This could lead to 
inhibition of dispersin and AAF which would severely impair the ability of the bacteria to confer adher-
ence and colonization. So far, none of the described toxins have shown to be under the control of AggR 
and these could therefore stay unaffected by an inhibition of AggR. This problem could be of minor im-
portance since an impairment of adherence would imply that bacteria would be unable to colonize and 
therefore get excreted with no exertion of pathogenesis. This course of action will have the advantage of 
controlling bacterial infections without promoting the evolution of resistance because it will not necessar-
ily be affecting normal growth of the pathogen (Sifri et al., 2005). 
Another approach could be the development of antibodies specific for AAFs and possibly giving rise to a 
vaccine. This would require a complete understanding of the different AAFs displayed by different EAEC 
strains. With the discovery of the new AAF designated AAF/IV it is suggested that most adherence factors 
are now characterized (Boisen et al., 2008). This could facilitate the development of a vaccine which 
would make most EAEC strains significantly less harmful.
An application of particular medical interest is the use of C. elegans to screen for drugs with anti-microbial 
or immune enhancing effects. The features which have established C. elegans as a useful organism in dif-
ferent parts of molecular science also makes it suitable to run high-throughput screens of drug candidates. 
Thus the nematode holds great promise in the development of new compounds to treat human pathogens.
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Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.2282
Are the survival curves sig. different No
No significant difference when comparing all curves of 042.
All 042 plates in the assay. No discrimination between GFP, nystatin, and normal.
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Appendix i
Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.4065
Are the survival curves sig. different No
No significant difference when comparing all curves of OP50.
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All OP50 plates in the assay. No discrimination between GFP, nystatin, and normal.
Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.1052
Are the survival curves sig. different No
All nystatin controlled 042 plates in the assay. No discrimination between GFP and non-GFP.
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Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.3097
Are the survival curves sig. different No
All nystatin controlled OP50 plates in the assay. No discrimination between GFP and non-GFP.
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Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.5934
Are the survival curves sig. different No
All normal and GFP-marked 042 plates in the assay.
Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.9845
Are the survival curves sig. different No
All normal and GFP-marked OP50 plates in the assay.
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Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.2282
Are the survival curves sig. different No
Plot of nystatin controlled and normal 042. No significant difference (P = 0.2282)
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Comparison of survival curves
Log-rank (Mantel-Cox) test
P value 0.4065
Are the survival curves sig. different No
Plot of nystatin controlled and normal OP50. No significant difference (P = 0.4065)
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